Jeff Caravella
No más puestos en curso
Fortuna: - $ al 30/04/2024
Perfil
Jeff Caravella served as the Chief Financial Officer at BioTheryX, Inc. and Medicenna Therapeutics Corp.
He received an undergraduate degree and an MBA from Syracuse University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/09/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Antiguos cargos conocidos de Jeff Caravella.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Director Financiero/CFO | 26/10/2023 |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Director Financiero/CFO | - |
Formación de Jeff Caravella.
| Syracuse University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MEDICENNA THERAPEUTICS CORP. | Health Technology |
| Empresas privadas | 1 |
|---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Jeff Caravella